Dr. Theepha Thayalakulasingam, MD

Dr. Thayalakulasingam practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Thayalakulasingam's NPI, 1356533749, was assigned on August 9, 2007. Dr. Thayalakulasingam holds Louisiana license 203978.

Dr. Thayalakulasingam's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Thayalakulasingam's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Thayalakulasingam is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Thayalakulasingam to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thayalakulasingam practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Thayalakulasingam's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Thayalakulasingam is licensed in Louisiana.

CMS data shows 1,378 Medicare services from Dr. Thayalakulasingam across 13 procedure codes in 2024, for 399 Medicare patients. Medicare paid $99,744 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 399 Medicare patients who saw Dr. Thayalakulasingam in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thayalakulasingam's median patient age at 69, with 57% women.

In 2024, Dr. Thayalakulasingam wrote 4,530 Medicare Part D claims for 503 patients. CMS names the drug for 4,349 of them, across 37 drugs with 11 or more claims each, at $1,206,137 in total drug cost. In 2023, CMS named 3,490 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Thayalakulasingam for performance year 2024, reported as part of a group. Dr. Thayalakulasingam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Thayalakulasingam, published from 2016 to 2023. Dr. Thayalakulasingam's most frequent co-authors are Lee Spindler Engel, MD, Robert Dirom Richards, MD and Gretchen Marie Yandle, MD.

CMS Open Payments shows 515 general payments to Dr. Thayalakulasingam from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. GlaxoSmithKline, LLC. paid the most, $2,759.